Home
About
Overview
Sharing Data
ORCID
Help
History (1)
IL6 inhibition in critically ill COVID-19 patients is associated with increased secondary infections.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
IL6 inhibition in critically ill COVID-19 patients is associated with increased secondary infections.
IL6 inhibition in critically ill COVID-19 patients is associated with increased secondary infections. medRxiv. 2020 Sep 12.
View in:
PubMed
authors with profiles
Lucas Kimmig
Gokhan M. Mutlu